company background image
ACTIVEFINE logo

Active Fine Chemicals DSE:ACTIVEFINE Stock Report

Last Price

৳14.40

Market Cap

৳3.5b

7D

-0.7%

1Y

-25.4%

Updated

18 Jun, 2024

Data

Company Financials

Active Fine Chemicals Limited

DSE:ACTIVEFINE Stock Report

Market Cap: ৳3.5b

ACTIVEFINE Stock Overview

Produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh.

ACTIVEFINE fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Active Fine Chemicals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Active Fine Chemicals
Historical stock prices
Current Share Price৳14.40
52 Week High৳21.50
52 Week Low৳11.90
Beta0.24
1 Month Change10.77%
3 Month Change-7.69%
1 Year Change-25.39%
3 Year Change-20.44%
5 Year Change-47.64%
Change since IPO-48.79%

Recent News & Updates

Recent updates

Shareholder Returns

ACTIVEFINEBD PharmaceuticalsBD Market
7D-0.7%1.1%0.1%
1Y-25.4%-24.1%-26.6%

Return vs Industry: ACTIVEFINE underperformed the BD Pharmaceuticals industry which returned -24.1% over the past year.

Return vs Market: ACTIVEFINE exceeded the BD Market which returned -26.6% over the past year.

Price Volatility

Is ACTIVEFINE's price volatile compared to industry and market?
ACTIVEFINE volatility
ACTIVEFINE Average Weekly Movement7.8%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement5.3%
10% most volatile stocks in BD Market7.7%
10% least volatile stocks in BD Market3.3%

Stable Share Price: ACTIVEFINE has not had significant price volatility in the past 3 months.

Volatility Over Time: ACTIVEFINE's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of BD stocks.

About the Company

FoundedEmployeesCEOWebsite
2004n/aS. M. Rahmanwww.afchem.com

Active Fine Chemicals Limited produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh. The company’s APIs include azithromycin dihydrate, erythromycin ethyl succinate, and erythromycin stearate for macrolide-antibiotics; esomeprazole magnesium trihydrates and pellets for anti-ulcerant; fluconazoles for anti-fungal; atorvastatin and rosuvastatin calcium for lipid-lowering; cetirizine and fexofenadine hydrochlorides, desloratadines, and ebastine for anti-histamine; and ciprofloxacin hydrochloride for anti-bacterial therapeutics. It also offers cefixime trihydrates and cefuroxime axetil for cephalosporin-antibiotics; metformin hydrochloride, sitagliptin phosphate monohydrate, vildagliptin, linagliptin, gliclizide, and glimepiride for anti-diabetic; pregabalin for anti-epileptic; paracetamol for analgesic and antipyrotic; losartan potassium and amlodipine besylate for anti-hypertensive; calcium orotate for use in calcium-supplement; sofosbuvir for anti-hepatitis-C; etoricoxib and ketorolac tromethamine for NSAID; and ticagrelor and amlodipine besylate for anti-platelet therapeutic areas, as well as solvents and powder reagents.

Active Fine Chemicals Limited Fundamentals Summary

How do Active Fine Chemicals's earnings and revenue compare to its market cap?
ACTIVEFINE fundamental statistics
Market cap৳3.46b
Earnings (TTM)-৳4.54m
Revenue (TTM)৳1.35b

2.6x

P/S Ratio

-760.6x

P/E Ratio

Is ACTIVEFINE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACTIVEFINE income statement (TTM)
Revenue৳1.35b
Cost of Revenue৳1.02b
Gross Profit৳336.56m
Other Expenses৳341.10m
Earnings-৳4.54m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.019
Gross Margin24.89%
Net Profit Margin-0.34%
Debt/Equity Ratio62.9%

How did ACTIVEFINE perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.